Timothy K. Andrews - General Counsel at Prometheus Biosciences, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Stock Option (Right to Buy)	54.1K			Nov 14, 2021	Direct	Common Stock

Showing 1 to 1 of 1 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.